nach oben

Drugs & Aging

Erschienen in:

01.11.2009 | Review Article

Quality of Life in Glaucoma and Three Other Chronic Diseases

A Systematic Literature Review

verfasst von: Tim Mills, Simon K. Law, John Walt, Patricia Buchholz, Jan Hansen

Erschienen in: Drugs & Aging | Ausgabe 11/2009

Einloggen, um Zugang zu erhalten

Abstract

Chronic diseases have a long-term negative impact on quality of life (QOL). Decreased QOL is associated with increased financial burden on healthcare systems and society. However, few publications have investigated the impact of glaucoma on patients’ QOL in comparison with other chronic diseases observed in patients with similar demographic characteristics.

To this end, a systematic literature search to assess QOL in glaucoma and three other chronic diseases (osteoporosis, type 2 diabetes mellitus and dementia) was performed. A total of 146 publications were identified that reported QOL using six commonly used generic QOL instruments: 36-, 12- and 20-item Short-Form Health Surveys (SF-36, -12 and -20), EuroQoL (EQ-5D), Sickness Impact Profile (SIP) and the Health Utilities Index-Mark III (HUI-III). The publication breakdown was as follows: glaucoma (10%), osteoporosis (26%), diabetes (52%) and dementia (12%); one publication assessed QOL in glaucoma, diabetes and dementia.

QOL was affected to a similar or slightly lesser degree by glaucoma than by osteoporosis, diabetes or dementia. Among the publications reporting SF- 36, -12 and -20 evaluations, physical component scores were generally lower than mental component scores across all diseases. QOL was affected more in patients with glaucoma than in demographically matched non-glaucomatous controls according to SF-20 assessment. EQ-5D and SIP results showed that QOL decreased as the severity of glaucoma increased. Patients with glaucoma had the lowest scores on the SIP instrument, indicating better QOL than patients with osteoporosis or diabetes (no data were available on dementia). The HUI-III instrument identified poorer QOL in patients with dementia than other diseases, probably due to cognitive deficits. However, for some of the instruments, data were scarce, and interpretation of the results should be conservative.

Although there are limited published QOL studies in glaucoma, its impact on QOL appears to be broadly similar to that of other serious chronic diseases. Development of a QOL instrument that measures vision-specific and general health aspects would better document the impact of glaucoma on QOL and would facilitate comparisons with other chronic disease states.

Ko Y, Coons SJ. Self-reported chronic conditions and EQ-5D index scores in the US adult population. Curr Med Res Opin 2006 Oct; 22(10): 2065–71PubMedCrossRef

Saarni SI, Harkanen T, Sintonen H, et al. The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res 2006 Oct; 15(8): 1403–14PubMedCrossRef

Gibson PR, Weston AR, Shann A, et al. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn’s disease. J Gastroenterol Hepatol 2007 Aug; 22(8): 1306–12PubMedCrossRef

Keranen T, Kaakkola S, Sotaniemi K, et al. Economic burden and quality of life impairment increase with severity of PD. Parkinsonism Relat Disord 2003 Jan; 9(3): 163–8PubMedCrossRef

Livingston G, Katona C, Roch B, et al. A dependency model for patients with Alzheimer’s disease: its validation and relationship to the costs of care: the LASER-AD Study. Curr Med Res Opin 2004 Jul; 20(7): 1007–16PubMedCrossRef

Severn P, Fraser S, Finch T, et al. Which quality of life score is best for glaucoma patients and why? BMC Oph-thalmol 2008; 8: 2CrossRef

Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006 Mar; 90(3): 262–7PubMedCrossRef

Clinical epidemiology of glaucoma. In: Allingham RR, Damji K, Freedman S, et al., editors. Shield’s textbook of glaucoma. 5th ed. Philadelphia (PA): Lippincott Williams and Wilkins, 2005

Mittmann N, Trakas K, Risebrough N, et al. Utility scores for chronic conditions in a community-dwelling population. Pharmacoeconomics 1999 Apr; 15(4): 369–76PubMedCrossRef

10.

Boisjoly H, Gresset J, Fontaine N, et al. The VF-14 index of functional visual impairment in candidates for a corneal graft. Am J Ophthalmol 1999 Jul; 128(1): 38–44PubMedCrossRef

11.

Cypel MC, Kasahara N, Atique D, et al. Quality of life in patients with glaucoma who live in a developing country. Int Ophthalmol 2004 Oct–Dec; 25(5-6): 267–72PubMedCrossRef

12.

Gordon MO, Kass MA. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol 1999 May; 117(5): 573–83PubMedCrossRef

13.

Javitt JC, Schiffman RM. Clinical success and quality of life with brimonidine 0.2% or timolol 0.5% used twice daily in glaucoma or ocular hypertension: a randomized clinical trial. Brimonidine Outcomes Study Group I. J Glaucoma 2000 Jun; 9(3): 224–34

14.

Nah YS, Seong GJ, Kim CY. Visual function and quality of life in Korean patients with glaucoma. Korean J Ophthalmol 2002 Dec; 16(2): 70–4PubMed

15.

Nesher R, Ticho U. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects. Isr Med Assoc J 2003 Apr; 5(4): 260–3PubMed

16.

Parrish 2nd RK, Gedde SJ, Scott IU, et al. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol 1997 Nov; 115(11): 1447–55PubMedCrossRef

17.

Wilson MR, Coleman AL, Yu F, et al. Functional status and well-being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. Ophthalmology 1998 Nov; 105(11): 2112–6PubMedCrossRef

18.

Ferrer M, Pellise F, Escudero O, et al. Validation of a minimum outcome core set in the evaluation of patients with back pain. Spine 2006 May 20; 31(12): 1372–9; discussion 80PubMedCrossRef

19.

Adachi JD, Loannidis G, Berger C, et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int 2001; 12(11): 903–8PubMedCrossRef

20.

Hall SE, Criddle RA, Comito TL, et al. A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int 1999; 9(6): 508–15PubMedCrossRef

21.

Hallberg I, Rosenqvist AM, Kartous L, et al. Health-related quality of life after osteoporotic fractures. Osteoporos Int 2004 Oct; 15(10): 834–41PubMedCrossRef

22.

Lombardi Jr I, Oliveira LM, Monteiro CR, et al. Evaluation of physical capacity and quality of life in osteoporotic women. Osteoporos Int 2004 Jan; 15(1): 80–5PubMedCrossRef

23.

Badia X, Diez-Perez A, Alvarez-Sanz C, et al. Measuring quality of life in women with vertebral fractures due to osteoporosis: a comparison of the OQLQ and QUALEFFO. Qual Life Res 2001; 10(4): 307–17PubMedCrossRef

24.

Dolan P, Torgerson D, Kakarlapudi TK. Health-related quality of life of Colles’ fracture patients. Osteoporos Int 1999; 9(3): 196–9PubMedCrossRef

25.

Cranney A, Coyle D, Pham BA, et al. The psychometric properties of patient preferences in osteoporosis. J Rheumatol 2001; 28(1): 132–7PubMed

26.

Gabriel SE, Kneeland TS, Melton 3rd LJ, et al. Health-related quality of life in economic evaluations for osteoporosis: whose values should we use? Med Decis Making 1999; 19(2): 141–8PubMedCrossRef

27.

Stoffel M, Wolf I, Ringel F, et al. Treatment of painful osteoporotic compression and burst fractures using kyphoplasty: a prospective observational design. J Neuro-surg Spine 2007; 6(4): 313–9CrossRef

28.

Tosteson AN, Gabriel SE, Kneeland TS, et al. Has the impact of hormone replacement therapy on health-related quality of life been undervalued? J Womens Health Gend Based Med 2000; 9(2): 119–30PubMedCrossRef

29.

Badia X, Prieto L, Roset M, et al. Development of a short osteoporosis quality of life questionnaire by equating items from two existing instruments. J Clin Epidemiol 2002; 55(1): 32–40PubMedCrossRef

30.

Cascella T, Musella T, Orio Jr F, et al. Effects of neri-dronate treatment in elderly women with osteoporosis [published erratum appears in J Endocrinol Invest 2005 May; 28 (5): IV]. J Endocrinol Invest 2005; 28(3): 202–8PubMed

31.

Chien MY, Yang RS, Tsauo JY. Home-based trunk-strengthening exercise for osteoporotic and osteopenic postmenopausal women without fracture: a pilot study [published erratum appears in Clin Rehabil 2005; 19 (5): 579]. Clin Rehabil 2005; 19(1): 28–36PubMedCrossRef

32.

Picavet HS, Hoeymans N. Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. Ann Rheum Dis 2004; 63(6): 723–9PubMedCrossRef

33.

Randell AG, Nguyen TV, Bhalerao N, et al. Deterioration in quality of life following hip fracture: a prospective study. Osteoporos Int 2000; 11(5): 460–6PubMedCrossRef

34.

Zoarski GH, Snow P, Olan WJ, et al. Percutaneous ver-tebroplasty for osteoporotic compression fractures: quantitative prospective evaluation of long-term outcomes. J Vasc Interv Radiol 2002; 13(2 Pt 1): 139–48PubMedCrossRef

35.

Pande I, Scott DL, O’Neill TW, et al. Quality of life, morbidity, and mortality after low trauma hip fracture in men. Ann Rheum Dis 2006 Jan; 65(1): 87–92PubMedCrossRef

36.

Papaioannou A, Joseph L, Ioannidis G, et al. Risk factors associated with incident clinical vertebral and non-vertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2005 May; 16(5): 568–78PubMedCrossRef

37.

Becker S, Garoscio M, Meissner J, et al. Is there an indication for prophylactic balloon kyphoplasty? A pilot study. Clin Orthop Relat Res 2007 May; 458: 83–9PubMed

38.

Do HM, Kim BS, Marcellus ML, et al. Prospective analysis of clinical outcomes after percutaneous vertebroplasty for painful osteoporotic vertebral body fractures. AJNR Am J Neuroradiol 2005 Aug; 26(7): 1623–8PubMed

39.

Khanna AJ, Reinhardt MK, Togawa D, et al. Functional outcomes of kyphoplasty for the treatment of osteoporotic and osteolytic vertebral compression fractures. Osteoporos Int 2006; 17(6): 817–26PubMedCrossRef

40.

Kocyigit H, Gulseren S, Erol A, et al. The reliability and validity of the Turkish version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Clin Rheumatol 2003; 22(1): 18–23PubMedCrossRef

41.

Marquis P, Cialdella P, De la Loge C. Development and validation of a specific quality of life module in postmenopausal women with osteoporosis: the QUALIOST. Qual Life Res 2001; 10(6): 555–66PubMedCrossRef

42.

Nguyen HV, Ludwig S, Gelb D. Osteoporotic vertebral burst fractures with neurologic compromise. J Spinal Disord Tech 2003; 16(1): 10–9PubMedCrossRef

43.

Trief PM, Wade MJ, Pine D, et al. A comparison of health-related quality of life of elderly and younger insulin-treated adults with diabetes. Age Ageing 2003 Nov; 32(6): 613–8PubMedCrossRef

44.

Schlotz W, Ambery P, Syddall HE, et al. Specific associations of insulin resistance with impaired health-related quality of life in the Hertfordshire Cohort Study. Qual Life Res 2007 Apr; 16(3): 429–36PubMedCrossRef

45.

Chittleborough CR, Baldock KL, Taylor AW, et al. Health status assessed by the SF-36 along the diabetes continuum in an Australian population. Qual Life Res 2006 May; 15(4): 687–94PubMedCrossRef

46.

Hermann BP, Vickrey B, Hays RD, et al. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res 1996 Oct; 25(2): 113–8PubMedCrossRef

47.

Boye KS, Matza LS, Oglesby A, et al. Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes. Health Qual Life Outcomes 2006; 4: 80CrossRef

48.

Currie CJ, Poole CD, Woehl A, et al. The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia 2006 Oct; 49(10): 2272–80PubMedCrossRef

49.

Camacho F, Anderson RT, Bell RA, et al. Investigating correlates of health related quality of life in a low-income sample of patients with diabetes. Qual Life Res 2002 Dec; 11(8): 783–96PubMedCrossRef

50.

De Berardis G, Pellegrini F, Franciosi M, et al. Longitudinal assessment of quality of life in patients with type 2 diabetes and self-reported erectile dysfunction. Diabetes Care 2005; 28(11): 2637–43PubMedCrossRef

51.

Edelman D, Olsen MK, Dudley TK, et al. Impact of diabetes screening on quality of life. Diabetes Care 2002 Jun; 25(6): 1022–6PubMedCrossRef

52.

Goldney RD, Phillips PJ, Fisher LJ, et al. Diabetes, depression, and quality of life: a population study. Diabetes Care 2004 May; 27(5): 1066–70PubMedCrossRef

53.

Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005 Jul; 28(7): 1568–73PubMedCrossRef

54.

Johnson JA, Nowatzki TE, Coons SJ. Health-related quality of life of diabetic Pima Indians. Medical Care 1996; 34(2): 97–102PubMedCrossRef

55.

Tang WL, Wang YM, Du WM, et al. Assessment of quality of life and relevant factors in elderly diabetic patients in the Shanghai community. Pharmacoepidemiol Drug Saf 2006; 15(2): 123–30PubMedCrossRef

56.

Adriaanse MC, Snoek FJ, Dekker JM, et al. No substantial psychological impact of the diagnosis of type 2 diabetes following targeted population screening: The Hoorn Screening Study. Diabet Med 2004; 21(9): 992–8PubMedCrossRef

57.

Gulseren L, Gulseren S, Hekimsoy Z, et al. Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients. Arch Med Res 2005 Mar–Apr; 36(2): 159–65PubMedCrossRef

58.

Hartley LA. Functional health status of persons with diabetes in a nurse-managed clinic. Diabetes Educ 2002; 28(1): 106–14PubMedCrossRef

59.

Kaholokula JK, Haynes SN, Grandinetti A, et al. Ethnic differences in the relationship between depressive symptoms and health-related quality of life in people with type 2 diabetes. Ethn Health 2006; 11(1): 59–80PubMedCrossRef

60.

Linzer M, Pierce C, Lincoln E, et al. Preliminary validation of a patient-based self-assessment measure of severity of illness in type 2 diabetes: results from the pilot phase of the Veterans Health Study. J Ambul Care Manag 2005; 28(2): 167–76

61.

Martinez-Castelao A, Gorriz JL, Garcia-Lopez F, et al. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study). J Nephrol 2004 Jul–Aug; 17(4): 544–51PubMed

62.

Rejeski WJ, Lang W, Neiberg RH, et al. Correlates of health-related quality of life in overweight and obese adults with type 2 diabetes. Obesity 2006; 14(5): 870–83PubMedCrossRef

63.

Thommasen HV, Berkowitz J, Thommasen AT, et al. Understanding relationships between diabetes mellitus and health-related quality of life in a rural community. Rural Remote Health 2005 Jul–Sep; 5(3): 441PubMed

64.

Klein BE, Klein R, Moss SE. Self-rated health and diabetes of long duration. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 1998; 21(2): 236–40

65.

Ohsawa I, Ishida T, Oshida Y, et al. Subjective health values of individuals with diabetes in Japan: comparison of utility values with the SF-36 scores. Diabetes Res Clin Pract 2003; 62(1): 9–16PubMedCrossRef

66.

Sedgwick JE, Pearce AJ, Gulliford MC. Evaluation of equity in diabetes health care in relation to African and Caribbean ethnicity. Ethn Health 2003; 8(2): 121–33PubMedCrossRef

67.

Smide B, Lukwale J, Msoka A, et al. Self-reported health and glycaemic control in Tanzanian and Swedish diabetic patients. J Adv Nurs 2002; 37(2): 182–91PubMedCrossRef

68.

Tapp RJ, Dunstan DW, Phillips P, et al. Association between impaired glucose metabolism and quality of life: results from the Australian Diabetes Obesity and Lifestyle Study. Diabetes Res Clin Pract 2006; 74(2): 154–61PubMedCrossRef

69.

Tilly KF, Belton AB, McLachlan JF. Continuous monitoring of health status outcomes: experience with a diabetes education program. Diabetes Educ 1995; 21(5): 413–9PubMedCrossRef

70.

Vinik AI, Zhang Q. Adding insulin glargine versus rosiglita-zone: health-related quality-of-life impact in type 2 diabetes [published erratum appears in Diabetes Care 2007 Jun; 30 (6): 1684]. Diabetes Care 2007; 30(4): 795–800PubMedCrossRef

71.

Ahroni JH, Boyko EJ. Responsiveness of the SF-36 among veterans with diabetes mellitus. J Diabetes Complications 2000; 14(1): 31–9PubMedCrossRef

72.

Claiborne N, Massaro E. Mental quality of life: an indicator of unmet needs in patients with diabetes. Soc Work Health Care 2000; 32(1): 25–43PubMedCrossRef

73.

Gulliford MC, Mahabir D. Relationship of health-related quality of life to symptom severity in diabetes mellitus: a study in Trinidad and Tobago. J Clin Epidemiol 1999; 52(8): 773–80PubMedCrossRef

74.

Hendra TJ, Taylor CD. A randomised trial of insulin on well-being and carer strain in elderly type 2 diabetic subjects. J Diabetes Complications 2004; 18(3): 148–54PubMedCrossRef

75.

Ibrahim IA, Beich J, Sidorov J, et al. Measuring outcomes of type 2 diabetes disease management program in an HMO setting. South Med J 2002; 95(1): 78–87PubMed

76.

Kuo HK, Jones RN, Milberg WP, et al. Effect of blood pressure and diabetes mellitus on cognitive and physical functions in older adults: a longitudinal analysis of the advanced cognitive training for independent and vital elderly cohort. J Am Geriatr Soc 2005 Jul; 53(7): 1154–61PubMedCrossRef

77.

Nerenz DR, Repasky DP, Whitehouse FW, et al. Ongoing assessment of health status in patients with diabetes mellitus. Med Care 1992; 30(5 Suppl.): MS112–24PubMedCrossRef

78.

Norholm V, Bech P. The WHO Quality of Life (WHO-QOL) Questionnaire: Danish validation study. Nord J Psychiatry 2001; 55(4): 229–35PubMedCrossRef

79.

Oka RK, Sanders MG. The impact of type 2 diabetes and peripheral arterial disease on quality of life. J Vasc Nurs 2005; 23(2): 61–6PubMedCrossRef

80.

Paschalides C, Wearden AJ, Dunkerley R, et al. The associations of anxiety, depression and personal illness representations with glycaemic control and health-related quality of life in patients with type 2 diabetes mellitus. J Psychosom Res 2004; 57(6): 557–64PubMedCrossRef

81.

Wee HL, Li SC, Cheung YB, et al. The influence of ethnicity on health-related quality of life in diabetes mellitus: a population-based, multiethnic study. J Diabetes Complications 2006; 20(3): 170–8PubMedCrossRef

82.

Weinberger M, Kirkman MS, Samsa GP, et al. The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Med Care 1994 Dec; 32(12): 1173–81PubMedCrossRef

83.

Patterson MB, Whitehouse PJ, Edland SD, et al. ADCS Prevention Instrument Project: quality of life assessment (QOL). Alzheimer Dis Assoc Disord 2006 Oct–Dec; 20(4 Suppl. 3): S179–90PubMedCrossRef

84.

Novella JL, Boyer F, Jochum C, et al. Health status in patients with Alzheimer’s disease: an investigation of inter-rater agreement. Qual Life Res 2006 Jun; 15(5): 811–9PubMedCrossRef

85.

Novella JL, Jochum C, Ankri J, et al. Measuring general health status in dementia: practical and methodological issues in using the SF-36. Aging (Milano) 2001 Oct; 13(5): 362–9

86.

Teri L, Gibbons LE, McCurry SM, et al. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA 2003 Oct 15; 290(15): 2015–22PubMedCrossRef

87.

Balkrishnan R, Bond JB, Byerly WG, et al. Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a Medicare health maintenance organization. Am J Geriatr Pharmacother 2003 Dec; 1(2): 75–81PubMedCrossRef

88.

Bellantonio S, Fortinsky R, Prestwood K. How well are community-living women treated for osteoporosis after hip fracture? J Am Geriatr Soc 2001 Sep; 49(9): 1197–204PubMedCrossRef

89.

Brenneman SK, Barrett-Connor E, Sajjan S, et al. Impact of recent fracture on health-related quality of life in postmenopausal women. J Bone Miner Res 2006 Jun; 21(6): 809–16PubMedCrossRef

90.

Brodaty H, Kemp NM, Low LF. Characteristics of the GPCOG, a screening tool for cognitive impairment. Int J Geriatr Psychiatry 2004 Sep; 19(9): 870–4PubMedCrossRef

91.

Cherry JC, Moffatt TP, Rodriguez C, et al. Diabetes disease management program for an indigent population empowered by telemedicine technology. Diabetes Technol Ther 2002; 4(6): 783–91PubMedCrossRef

92.

Cockerill W, Lunt M, Silman AJ, et al. Health-related quality of life and radiographic vertebral fracture. Os-teoporos Int 2004 Feb; 15(2): 113–9CrossRef

93.

Jackson JC, Hart RP, Gordon SM, et al. Six-month neu-ropsychological outcome of medical intensive care unit patients. Crit Care Med 2003 Apr; 31(4): 1226–34PubMedCrossRef

94.

Johnson JA, Maddigan SL. Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes. Qual Life Res 2004 Mar; 13(2): 449–56PubMedCrossRef

95.

Lange LJ, Piette JD. Personal models for diabetes in context and patients’ health status. J Behav Med 2006 Jun; 29(3): 239–53PubMedCrossRef

96.

Logtenberg SJ, van Ballegooie E, Israel-Bultman H, et al. Glycaemic control, health status and treatment satisfaction with continuous intraperitoneal insulin infusion. Neth J Med 2007 Feb; 65(2): 65–70PubMed

97.

McCollum M, Ellis SL, Regensteiner JG, et al. Minor depression and health status among US adults with diabetes mellitus. Am J Manag Care 2007 Feb; 13(2): 65–72PubMed

98.

McCollum M, Hansen LS, Lu L, et al. Gender differences in diabetes mellitus and effects on self-care activity. Gend Med 2005 Dec; 2(4): 246–54PubMedCrossRef

99.

Ng TP, Feng L, Chiam PC, et al. Psychiatric morbidity and acute hospitalization in elderly people. Int Psychogeriatr 2006 Dec; 18(4): 701–11PubMedCrossRef

100.

Nichols GA, Brown JB. Functional status before and after diagnosis of type 2 diabetes. Diabet Med 2004 Jul; 21(7): 793–7PubMedCrossRef

101.

Palussiere J, Berge J, Gangi A, et al. Clinical results of an open prospective study of a bis-GMA composite in percutaneous vertebral augmentation. Eur Spine J 2005 Dec; 14(10): 982–91PubMedCrossRef

102.

Piette JD, Wagner TH, Potter MB, et al. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care 2004 Feb; 42(2): 102–9PubMedCrossRef

103.

Sundaram M, Kavookjian J, Patrick JH, et al. Quality of life, health status and clinical outcomes in type 2 diabetes patients. Qual Life Res 2007 Mar; 16(2): 165–77PubMedCrossRef

104.

Sherwood MB, Garcia-Siekavizza A, Meltzer MI, et al. Glaucoma’s impact on quality of life and its relation to clinical indicators: a pilot study. Ophthalmology 1998 Mar; 105(3): 561–6PubMedCrossRef

105.

Ahroni JH, Boyko EJ, Davignon DR, et al. The health and functional status of veterans with diabetes. Diabetes Care 1994 Apr; 17(4): 318–21PubMedCrossRef

106.

Glasgow RE, Ruggiero L, Eakin EG, et al. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997 Apr; 20(4): 562–7PubMedCrossRef

107.

Hanninen J, Takala J, Keinanen-Kiukaanniemi S. Quality of life in NIDDM patients assessed with the SF-20 questionnaire. Diabetes Res Clin Pract 1998 Oct; 42(1): 17–27PubMedCrossRef

108.

Stover JC, Skelly AH, Holditch-Davis D, et al. Perceptions of health and their relationship to symptoms in African American women with type 2 diabetes. Appl Nurs Res 2001 May; 14(2): 72–80PubMedCrossRef

109.

Westaway MS, Rheeder P, Gumede T. The effect of type 2 diabetes mellitus on health-related quality of life (HRQOL). Curationis 2001 Mar; 24(1): 74–8PubMedCrossRef

110.

Westaway MS, Seager JR, Rheeder P, et al. The effects of social support on health, well-being and management of diabetes mellitus: a black South African perspective. Ethn Health 2005 Feb; 10(1): 73–89PubMedCrossRef

111.

Kobelt G, Jonsson B, Bergstrom A, et al. Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden. Acta Ophthalmol Scand 2006 Jun; 84(3): 363–71PubMedCrossRef

112.

Montemayor F, Sibley LM, Courtright P, et al. Contribution of multiple glaucoma medications to visual function and quality of life in patients with glaucoma. Can J Ophthalmol 2001 Dec; 36(7): 385–90PubMed

113.

Borgstrom F, Zethraeus N, Johnell O, et al. Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 2006; 17(5): 637–50PubMedCrossRef

114.

Dhillon V, Hurst N, Hannan J, et al. Association of low general health status, measured prospectively by Euro-QoL EQ-5D, with osteoporosis, independent of a history of prior fracture. Osteoporos Int 2005 May; 16(5): 483–9PubMedCrossRef

115.

Guilera M, Fuentes M, Grifols M, et al. Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study. Osteoporos Int 2006; 17(5): 664–71PubMedCrossRef

116.

Jakob F, Marin F, Martin-Mola E, et al. Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). QJM 2006 Aug; 99(8): 531–43PubMedCrossRef

117.

Kumar K, Verma AK, Wilson J, et al. Vertebroplasty in osteoporotic spine fractures: a quality of life assessment. Can J Neurol Sci 2005 Nov; 32(4): 487–95PubMed

118.

Oleksik A, Lips P, Dawson A, et al. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res 2000 Jul; 15(7): 1384–92PubMedCrossRef

119.

Bech P, Moses R, Gomis R. The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharma-cotherapy naive type 2 diabetes: a placebo-controlled, multicentre study. Qual Life Res 2003 Jun; 12(4): 413–25PubMedCrossRef

120.

Currie CJ, McEwan P, Peters JR, et al. The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): descriptive analysis from the first 20,000 subjects. Value Health 2005 Sep–Oct; 8(5): 581–90PubMedCrossRef

121.

Koopmanschap M. Coping with type II diabetes: the patient’s perspective. Diabetologia 2002 Jul; 45(7): S18–22PubMed

122.

Lucioni C, Garancini MP, Massi-Benedetti M, et al. The costs of type 2 diabetes mellitus in Italy: a CODE-2 sub-study. Treat Endocrinol 2003; 2(2): 121–33PubMedCrossRef

123.

Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications 2000 Sep–Oct; 14(5): 235–41PubMedCrossRef

124.

Redekop WK, Koopmanschap MA, Stolk RP, et al. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002 Mar; 25(3): 458–63PubMedCrossRef

125.

Sakamaki H, Ikeda S, Ikegami N, et al. Measurement of HRQL using EQ-5D in patients with type 2 diabetes mellitus in Japan. Value Health 2006 Jan–Feb; 9(1): 47–53PubMedCrossRef

126.

Andersen CK, Wittrup-Jensen KU, Lolk A, et al. Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health Qual Life Outcomes 2004; 2: 52PubMedCrossRef

127.

Ankri J, Beaufils B, Novella JL, et al. Use of the EQ-5D among patients suffering from dementia. J Clin Epidemiol 2003 Nov; 56(11): 1055–63PubMedCrossRef

128.

Bryan S, Hardyman W, Bentham P, et al. Proxy completion of EQ-5D in patients with dementia. Qual Life Res 2005 Feb; 14(1): 107–18PubMedCrossRef

129.

Coucill W, Bryan S, Bentham P, et al. EQ-5D in patients with dementia: an investigation of inter-rater agreement. Med Care 2001 Aug; 39(8): 760–71PubMedCrossRef

130.

Naglie G, Tomlinson G, Tansey C, et al. Utility-based quality of life measures in Alzheimer’s disease. Qual Life Res 2006 May; 15(4): 631–43PubMedCrossRef

131.

Selwood A, Thorgrimsen L, Orrell M. Quality of life in dementia — a one-year follow-up study. Int J Geriatr Psychiatry 2005 Mar; 20(3): 232–7PubMedCrossRef

132.

Serrano-Aguilar PG, Lopez-Bastida J, Yanes-Lopez V. Impact on health-related quality of life and perceived burden of informal caregivers of individuals with Alzheimer’s disease. Neuroepidemiology 2006; 27(3): 136–42PubMedCrossRef

133.

Thorgrimsen L, Selwood A, Spector A, et al. Whose quality of life is it anyway? The validity and reliability of the Quality of Life-Alzheimer’s Disease (QOL-AD) scale. Alzheimer Dis Assoc Disord 2003 Oct–Dec; 17(4): 201–8PubMedCrossRef

134.

Vogel A, Mortensen EL, Hasselbalch SG, et al. Patient versus informant reported quality of life in the earliest phases of Alzheimer’s disease. Int J Geriatr Psychiatry 2006 Dec; 21(12): 1132–8PubMedCrossRef

135.

Janz NK, Wren PA, Lichter PR, et al. Quality of life in newly diagnosed glaucoma patients: the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2001 May; 108(5): 887–97; discussion 98PubMedCrossRef

136.

Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology 2001 Nov; 108(11): 1954–65PubMedCrossRef

137.

De Grauw WJ, van de Lisdonk EH, Behr RR, et al. The impact of type 2 diabetes mellitus on daily functioning. Fam Pract 1999 Apr; 16(2): 133–9PubMedCrossRef

138.

De Grauw WJ, van de Lisdonk EH, van Gerwen WH, et al. Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life? Br J Gen Pract 2001 Jul; 51(468): 527–32PubMed

139.

Mueller MJ, Salsich GB, Strube MJ. Functional limitations in patients with diabetes and transmetatarsal amputations. Phys Ther 1997 Sep; 77(9): 937–43PubMed

140.

Papaioannou A, Adachi JD, Winegard K, et al. Efficacy of home-based exercise for improving quality of life among elderly women with symptomatic osteoporosis-related vertebral fractures. Osteoporos Int 2003 Aug; 14(8): 677–82PubMedCrossRef

141.

Bowker SL, Pohar SL, Johnson JA. A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer. Health Qual Life Outcomes 2006; 4: 17PubMedCrossRef

142.

Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002 Jul–Aug; 22(4): 340–9PubMed

143.

Maddigan SL, Feeny DH, Johnson JA. A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes. Med Decis Making 2003 Nov–Dec; 23(6): 489–501PubMedCrossRef

144.

Maddigan SL, Feeny DH, Johnson JA. Construct validity of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes. Qual Life Res 2004 Mar; 13(2): 435–48PubMedCrossRef

145.

Maddigan SL, Feeny DH, Johnson JA. Health-related quality of life deficits associated with diabetes and co-morbidities in a Canadian National Population Health Survey. Qual Life Res 2005 Jun; 14(5): 1311–20PubMedCrossRef

146.

Maddigan SL, Feeny DH, Majumdar SR, et al. Health Utilities Index Mark 3 demonstrated construct validity in a population-based sample with type 2 diabetes. J Clin Epidemiol 2006 May; 59(5): 472–7PubMedCrossRef

147.

Maddigan SL, Majumdar SR, Guirguis LM, et al. Improvements in patient-reported outcomes associated with an intervention to enhance quality of care for rural patients with type 2 diabetes: results of a controlled trial. Diabetes Care 2004 Jun; 27(6): 1306–12PubMedCrossRef

148.

Mo F, Morrison H, Choi BC, et al. Evaluation and measurement of health-related quality of life for individuals with diabetes mellitus by Health Utilities Index Mark 3 (HUI3) system. Scientific World Journal 2006; 6: 1412–23PubMedCrossRef

149.

Roberts VL, Stewart J, Issa M, et al. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidi-nedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 2005 Oct; 27(10): 1535–47PubMedCrossRef

150.

Wexler DJ, Grant RW, Wittenberg E, et al. Correlates of health-related quality of life in type 2 diabetes. Diabeto-logia 2006 Jul; 49(7): 1489–97CrossRef

151.

Sawka AM, Thabane L, Papaioannou A, et al. Health Utilities Index 3 scores in osteoporosis compared to other chronic medical conditions: a population-based study from the Canadian Multicentre Osteoporosis Study (CaMos) [abstract no. SA455]. J Bone Miner Res 2004; 19 Suppl.: S180

152.

Sawka AM, Thabane L, Papaioannou A, et al. Health-related quality of life measurements in elderly Canadians with osteoporosis compared to other chronic medical conditions: a population-based study from the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2005 Dec; 16(12): 1836–40PubMedCrossRef

153.

Walsh JB, Cleall S, Fahrlejtner A, et al. Quality of life and back pain in the European Forsteo Observational Study-EFOS [abstract no. SU392]. J Bone Miner Res 2006; 21 (Suppl.): S305

154.

Neumann PJ, Sandberg EA, Araki SS, et al. A comparison of HUI2 and HUI3 utility scores in Alzheimer’s disease. Med Decis Making 2000 Oct–Dec; 20(4): 413–22PubMedCrossRef

155.

Carver DJ, Chapman CA, Thomas VS, et al. Validity and reliability of the Medical Outcomes Study Short Form-20 questionnaire as a measure of quality of life in elderly people living at home. Age Ageing 1999 Mar; 28(2): 169–74PubMedCrossRef

156.

Horsman J, Furlong W, Feeny D, et al. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes 2003; 1: 54PubMedCrossRef

157.

Espallargues M, Czoski-Murray CJ, Bansback NJ, et al. The impact of age-related macular degeneration on health status utility values. Invest Ophthalmol Vis Sci 2005 Nov; 46(11): 4016–23PubMedCrossRef

158.

Katz JN, Larson MG, Phillips CB, et al. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992 Oct; 30(10): 917–25PubMedCrossRef

159.

Neudert C, Wasner M, Borasio GD. Patients’ assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQOL-DW in patients with amyo-trophic lateral sclerosis. J Neurol Sci 2001 Oct 15; 191(1-2): 103–9PubMedCrossRef

160.

Stucki G, Liang MH, Phillips C, et al. The Short Form-36 is preferable to the SIP as a generic health status measure in patients undergoing elective total hip arthroplasty. Arthritis Care Res 1995 Sep; 8(3): 174–81PubMedCrossRef

Titel: Quality of Life in Glaucoma and Three Other Chronic Diseases
A Systematic Literature Review
verfasst von: Tim Mills
Simon K. Law
John Walt
Patricia Buchholz
Jan Hansen
Publikationsdatum: 01.11.2009
Verlag: Springer International Publishing
Erschienen in: Drugs & Aging / Ausgabe 11/2009
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI: https://doi.org/10.2165/11316830-000000000-00000

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2009

Cerebrolysin

Medication-Related Admissions in Older People

Health State Values during the First Year of Drug Treatment in Early-Stage Parkinson’s Disease

Lipid-Lowering Therapy for the Primary Prevention of Cardiovascular Disease in the Elderly